Literature DB >> 16842572

Public health impact of isoniazid-resistant Mycobacterium tuberculosis strains with a mutation at amino-acid position 315 of katG: a decade of experience in The Netherlands.

H R van Doorn1, P E W de Haas, K Kremer, C M J E Vandenbroucke-Grauls, M W Borgdorff, D van Soolingen.   

Abstract

A previous limited study demonstrated that Mycobacterium tuberculosis isolates with a mutation at amino-acid position 315 of katG (Delta315) exhibited high-level resistance to isoniazid and were more frequently resistant to streptomycin. In the present study, isoniazid-resistant M. tuberculosis isolates from 8,332 patients in The Netherlands (1993-2002) were screened for the Delta315 mutation. Isoniazid resistance was found in 592 (7%) isolates, of which 323 (55%) carried Delta315. IS6110 restriction fragment length polymorphism analysis showed that Delta315 isolates occurred in clusters, suggesting recent transmission, at the same frequency as isoniazid-susceptible isolates. In contrast, other isoniazid-resistant isolates clustered significantly less frequently. Delta315 isolates were high-level isoniazid-resistant, streptomycin-resistant and multidrug-resistant significantly more often, and may have a greater impact on public health, than other isoniazid-resistant isolates.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16842572     DOI: 10.1111/j.1469-0691.2006.01495.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  21 in total

1.  Rapid Detection of Mycobacterium tuberculosis Strains Resistant to Isoniazid and/or Rifampicin: Standardization of Multiplex Polymerase Chain Reaction Analysis.

Authors:  Jimena Collantes; Francesca Barletta Solari; Leen Rigouts
Journal:  Am J Trop Med Hyg       Date:  2016-10-24       Impact factor: 2.345

2.  Identification of katG mutations associated with high-level isoniazid resistance in Mycobacterium tuberculosis.

Authors:  Hiroki Ando; Yuji Kondo; Toshinori Suetake; Emiko Toyota; Seiya Kato; Toru Mori; Teruo Kirikae
Journal:  Antimicrob Agents Chemother       Date:  2010-03-08       Impact factor: 5.191

3.  Spoligotype-based comparative population structure analysis of multidrug-resistant and isoniazid-monoresistant Mycobacterium tuberculosis complex clinical isolates in Poland.

Authors:  Tomasz Jagielski; Ewa Augustynowicz-Kopec; Thierry Zozio; Nalin Rastogi; Zofia Zwolska
Journal:  J Clin Microbiol       Date:  2010-09-01       Impact factor: 5.948

Review 4.  Genotyping of Mycobacterium tuberculosis: application in epidemiologic studies.

Authors:  Midori Kato-Maeda; John Z Metcalfe; Laura Flores
Journal:  Future Microbiol       Date:  2011-02       Impact factor: 3.165

Review 5.  The heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosis.

Authors:  Borna Müller; Sonia Borrell; Graham Rose; Sebastien Gagneux
Journal:  Trends Genet       Date:  2012-12-13       Impact factor: 11.639

6.  Molecular epidemiology of tuberculosis in foreign-born persons living in San Francisco.

Authors:  Gompol Suwanpimolkul; Leah G Jarlsberg; Jennifer A Grinsdale; Dennis Osmond; L Masae Kawamura; Philip C Hopewell; Midori Kato-Maeda
Journal:  Am J Respir Crit Care Med       Date:  2013-05-01       Impact factor: 21.405

7.  Epidemiology of isoniazid resistance mutations and their effect on tuberculosis treatment outcomes.

Authors:  Mai N T Huyen; Frank G J Cobelens; Tran N Buu; Nguyen T N Lan; Nguyen H Dung; Kristin Kremer; Edine W Tiemersma; Dick van Soolingen
Journal:  Antimicrob Agents Chemother       Date:  2013-05-20       Impact factor: 5.191

8.  A close-up on the epidemiology and transmission of multidrug-resistant tuberculosis in Poland.

Authors:  T Jagielski; A Brzostek; A van Belkum; J Dziadek; E Augustynowicz-Kopeć; Z Zwolska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-07-20       Impact factor: 3.267

9.  Resistant mutants of Mycobacterium tuberculosis selected in vitro do not reflect the in vivo mechanism of isoniazid resistance.

Authors:  Indra L Bergval; Anja R J Schuitema; Paul R Klatser; Richard M Anthony
Journal:  J Antimicrob Chemother       Date:  2009-07-04       Impact factor: 5.790

10.  Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America.

Authors:  Elis R Dalla Costa; Marta O Ribeiro; Márcia S N Silva; Liane S Arnold; Diana C Rostirolla; Patricia I Cafrune; Roger C Espinoza; Moises Palaci; Maria A Telles; Viviana Ritacco; Philip N Suffys; Maria L Lopes; Creuza L Campelo; Silvana S Miranda; Kristin Kremer; Pedro E Almeida da Silva; Leila de Souza Fonseca; John L Ho; Afrânio L Kritski; Maria L R Rossetti
Journal:  BMC Microbiol       Date:  2009-02-19       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.